BLUE trade ideas
Beautiful Setup on Bird - Longterm tradeLongterm trade - With Covid slowly fading and schools getting back to normal, Biden Admiinsteration, and electric buses, Bird right now is one of the major Bus manufacturers that are already manufacturing electric buses and selling them. Both fundemental and technical analysis.
Only for investors : Biotech For those looking to diversify their portfolio or a long-term investment. Here I bring you an option in the biotech sector: Bluebird Bio INC, the leader in targeted cell therapy.
This stock is in an important support area. It is a zone where buyers will seek to accumulate to buy cheap. the risk in this operation is low compared to the profit potential
Huge volatility expected in Bluebird Bio on Trial Data ReleaseThe options market is expecting huge moves tomorrow in the Bio company BLUE as the update investors on the trial data listed below. Keep strong watch there could be enormous volume in the coming days.
Phase 3 data for LentiGlobin in HGB-212 (transfusion-dependent beta thalassemia), June 14; updated Phase 1/2 data for LentiGlobin in HGB-204 (beta-thalassemia), June 14; updated Phase 3 data for LentiGlobin in HGB-207, June 14.
COMPANY PROFILE
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
